The Business Journal found 21 Massachusetts life sciences companies announced layoffs impacting at least 1,000 employees ...

The exemption may be short-lived if President Trump makes good on threats to use tariffs as leverage to bring drug production ...

The Boston biotech is also looking into "strategic options" after its only clinical-stage drug showed disappointing Phase 1 ...

British biotech CellCentric is settling into a new office in Boston, part of the company’s expansion into the U.S. as ...

“Lots of companies are limping along,” said Mani Foroohar, senior research analyst at Boston health care investment bank Leerink Partners. Foroohar, a top biotech analyst, has slapped an ...

Worcester will host its first-ever Startup Week, with three days of panels, pitch competitions, and company visits. In June, ...

More than three-quarters of private biotech investment tracked by BioPharma Dive between January and March was distributed ...

But what it does have is its critical role—albeit underrated—as a biotech hub. Competing with South San Francisco and Boston, ...

We recently published a list of 10 Best Healthcare Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Boston Scientific Corporation (NYSE:BSX) stands ...

The Boston biotech scene’s a mess, and Marty Makary’s and Jay Bhattacharya’s nominations have been advanced to the full Senate for FDA and NIH leadership. Also, we see another company ...

even as neighborhoods like Allston and Boston suburbs see an uptick in biotech companies. Early stage innovation, development, and experimentation is being increasingly outsourced to startups like ...

This was supposed to be the year of biotech’s comeback. At least that was the hope of many in the sector who started 2025 pointing to scientific advances and falling interest rates. Some foresaw ...